Literature DB >> 20407685

Hydroxylamine-amplified gold nanoparticles for the homogeneous detection of sequence-specific DNA.

Aiping Fan1, Sheng Cai, Zhijuan Cao, Choiwan Lau, Jianzhong Lu.   

Abstract

Herein, we report the development of a simple, sensitive, inexpensive, and homogeneous detection method for the analysis of DNA hybridization based on the optical properties of hydroxylamine-amplified gold nanoparticles (Au NPs) in solution phase. The assay relies on a sandwich-type DNA hybridization in which DNA targets are first hybridized with capture DNA probes immobilized on the surface of magnetic beads and then sandwiched with Au NPs modified with biotinylated reporter DNA. Au NPs, after being anchored on the magnetic beads, are then dispersed in solution by the dehybridization and enlarged by using a mixture of HAuCl(4) and NH(2)OH. The Au NP growth signal which is used for the quantitative analysis of sequence-specific DNA can be easily monitored by the naked eye directly or an UV-vis spectrophotometer. Surface plasmonic signature of the enlarged Au NPs and the kinetics of the Au NP growth in the homogenous phase containing of HAuCl(4) and NH(2)OH have also been studied. As a result, such a homogeneous assay allows the detection of 30-base DNA targets down to the 100 amol level, which offers great promise for facilitating sensitive detection of other biorecognition events.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20407685     DOI: 10.1039/c0an00007h

Source DB:  PubMed          Journal:  Analyst        ISSN: 0003-2654            Impact factor:   4.616


  2 in total

1.  Magnetic bead-based colorimetric immunoassay for aflatoxin B1 using gold nanoparticles.

Authors:  Xu Wang; Reinhard Niessner; Dietmar Knopp
Journal:  Sensors (Basel)       Date:  2014-11-14       Impact factor: 3.576

Review 2.  Using gold nanoparticles to detect single-nucleotide polymorphisms: toward liquid biopsy.

Authors:  María Sanromán Iglesias; Marek Grzelczak
Journal:  Beilstein J Nanotechnol       Date:  2020-01-31       Impact factor: 3.649

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.